Serum zonulin in patients with inflammatory bowel disease: a pilot study-Reference-Cited by-同舟云学术

Serum zonulin in patients with inflammatory bowel disease: a pilot study

Published:2019-02 Issue:2 Volume:110 Page:
ISSN:0026-4806
Container-title:Minerva Medica
language:
Short-container-title:Minerva Med

Author:

Caviglia Gian Paolo,Dughera Francesca,Ribaldone Davide G.,Rosso Chiara,Abate Maria L.,Pellicano Rinaldo,Bresso Francesca,Smedile Antonina,Saracco Giorgio M.,Astegiano Marco

Publisher

Edizioni Minerva Medica

Subject

General Medicine

Link

https://www.minervamedica.it/pdf.php?cod=R10Y2019N02A0095

Reference23 articles.

1. Biosimilars in inflammatory bowel disease;Gargallo CJ;Minerva Med,2017

2. Features of inflammatory bowel disease followed in a second level center in Northern Italy;Ribaldone DG;Minerva Med,2017

3. Intestinal barrier dysfunction in inflammatory bowel diseases

4. ADAM17 and gastrointestinal tract diseases: clinical aspects with translational messages

5. Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Faecal Zonulin and Calprotectin Levels Be Used in the Diagnosis and Follow-Up in Infants with Milk Protein-Induced Allergic Proctocolitis?;Nutrients;2024-09-02

2. Repurposing metformin as adjuvant therapy in patients with ulcerative colitis treated with mesalamine: A randomized controlled double-blinded study;International Immunopharmacology;2024-09

4. Hyphae and Healthspan;2024-08-06

5. Hyphae and Healthspan;2024-08-01